Recently published research from Global Markets Direct, "Trimel BioPharma SRL - Product Pipeline Review - 2012", is now available at Fast Market Research
Boston, MA -- (SBWIRE) -- 02/25/2013 -- Global Market Direct's pharmaceuticals report, "Trimel BioPharma SRL - Product Pipeline Review - 2012" provides data on the Trimel BioPharma SRL's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Trimel BioPharma SRL's corporate website, SEC filings, investor presentations and featured press releases, both from Trimel BioPharma SRL and industry-specific third party sources, put together by Global Markets Direct's team.
- Trimel BioPharma SRL - Brief Trimel BioPharma SRL overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Trimel BioPharma SRL human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Trimel BioPharma SRL with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Trimel BioPharma SRL's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
View Full Report Details and Table of Contents
Reasons to Get this Report
- Evaluate Trimel BioPharma SRL's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Trimel BioPharma SRL in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Trimel BioPharma SRL's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Trimel BioPharma SRL.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Trimel BioPharma SRL and identify potential opportunities in those areas.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- HanAll Biopharma Co., Ltd. - Product Pipeline Review - 2012
- Hemispherx Biopharma, Inc. - Product Pipeline Review - 2012
- Lytix Biopharma AS - Product Pipeline Review - 2012
- Array BioPharma Inc. - Product Pipeline Review - 2012
- Synageva BioPharma Corp. - Product Pipeline Review - 2012
- ARCA biopharma, Inc. - Product Pipeline Review - 2012
- Can-Fite BioPharma Ltd. - Product Pipeline Review - 2012
- A. Menarini Industrie Farmaceutiche Riunite Srl - Product Pipeline Review - 2012
- CeNeRx BioPharma, Inc. - Product Pipeline Review - 2012
- ViroStatics, srl - Product Pipeline Review - 2012
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)